|
PAZIT Clinical Trial
|
|
0
|
2213
|
May 8, 2017
|
|
Olaratumab(Lartruvo) with Pembrolizumab (Keytruda)
|
|
1
|
2902
|
April 29, 2017
|
|
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation
|
|
0
|
2180
|
April 19, 2017
|
|
Olaratumab with Doxorubicin
|
|
13
|
4179
|
April 18, 2017
|
|
Trametinib (GSK1120212) combined with Pazopanib(Votrient)?
|
|
1
|
2268
|
April 6, 2017
|
|
G100 Phase 1 Trial Results
|
|
0
|
2144
|
April 4, 2017
|
|
NBTXR3 Clinical Trial
|
|
2
|
2562
|
March 24, 2017
|
|
Trabectedin Combined with Durvalumab
|
|
0
|
2101
|
March 21, 2017
|
|
Optical Coherence Tomography
|
|
0
|
2126
|
March 21, 2017
|
|
Study of Selinexor and Doxorubicin
|
|
1
|
2439
|
March 21, 2017
|
|
Palifosfamide
|
|
0
|
2128
|
March 21, 2017
|
|
Talimogene Laherparepvec
|
|
1
|
2446
|
March 16, 2017
|
|
Regorafenib
|
|
2
|
2877
|
March 15, 2017
|
|
Trabectedin (Yondelis) In Advanced Synovial Sarcoma, Retrospective Study from Europe
|
|
2
|
2334
|
March 14, 2017
|
|
Gpx-150
|
|
0
|
2260
|
February 23, 2017
|
|
Presage's CIVO Device
|
|
0
|
2262
|
February 21, 2017
|
|
Pembrolizumab + Doxorubicin
|
|
3
|
2582
|
February 21, 2017
|
|
Lung Metastasis Mimic
|
|
1
|
2302
|
January 28, 2017
|
|
Cancer Cells Metabolism
|
|
0
|
2436
|
January 25, 2017
|
|
Anlotinib
|
|
0
|
2320
|
January 12, 2017
|
|
Results of the International Collaborative Study on Synovial Sarcoma
|
|
5
|
2676
|
January 12, 2017
|
|
Lutathera
|
|
3
|
2547
|
January 8, 2017
|
|
Ribociclib and Doxorubicin
|
|
0
|
2224
|
January 5, 2017
|
|
CBT-1 with Doxorubicin
|
|
0
|
2462
|
January 5, 2017
|
|
Immunotherapy for Sarcoma
|
|
0
|
2409
|
December 7, 2016
|
|
DHEA Trial For Synovial Sarcoma
|
|
2
|
3026
|
December 6, 2016
|
|
Identifying the Molecular Determinants of Pazopanib Response in Advanced Soft Tissue Sarcoma
|
|
0
|
2201
|
November 2, 2016
|
|
Tivozanib
|
|
2
|
2458
|
October 27, 2016
|
|
Epirubicin and ifosfamide
|
|
0
|
2224
|
October 11, 2016
|
|
Decitabine, Tetrahydrouridine with or without Celecoxib
|
|
0
|
2198
|
October 4, 2016
|